ArticleCureus2026

PIK3CA-Mutant Non-Small Cell Lung Cancer Refractory to Two Lines of Chemoimmunotherapy: A Case Report.

Takayuki Higashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.